Apellis Pharmaceuticals, Inc. (APLS)
Data as of , from SEC Form 4 filings.
See up to 3 months of APLS. The 7-day demo opens the 1M and 3M ranges and puts APLS on your watchlist.
Start 7-day demoLatest APLS insider trades
Mark Jeffrey Delong - OfficerOpen-market sale$8K
A. Sinclair DunlopOther161,567 sh- A. Sinclair Dunlop
About Apellis Pharmaceuticals, Inc. (APLS)
Apellis Pharmaceuticals, Inc. is an SEC registrant, filing under CIK 0001492422, classified as pharmaceutical preparations. We track it alongside the rest of the Health Care sector.
APLS Form 4 activity by transaction type, last 90 days
No Form 4 activity for APLS in the last 90 days.
APLS insider transactions (Form 4)
3289 Form 4 filings on record, the earliest from Nov 1, 2024, newest first. Filing history page 2 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
 Nur Nicholson - Officer | Grant or award | Common Stock | 45,220 footnote F1 | $0.00 | - | |
| ||||||
 Timothy Eugene Sullivan - Officer | Grant or award | Common Stock | 58,140 footnote F1 | $0.00 | - | |
| ||||||
 David O. Watson - Officer | Grant or award | Common Stock | 55,986 footnote F1 | $0.00 | - | |
| ||||||
 Cedric Francois - Officer | Grant or award | Common Stock | 195,952 footnote F1 | $0.00 | - | |
| ||||||
| Caroline Baumal - Officer | Open-market sale | Common Stock | 2,797 | $21.77 | $61K | |
| James George Chopas - Officer | Open-market sale | Common Stock | 2,064 | $21.77 | $45K | |
| Mark Jeffrey Delong - Officer | Open-market sale | Common Stock | 3,371 | $21.77 | $73K | |
 Pascal Deschatelets - Officer | Open-market sale | Common Stock | 5,928 | $21.77 | $129K | |
| Cedric Francois - Officer | Open-market sale | Common Stock | 27,192 | $21.77 | $592K | |
| Nur Nicholson - Officer | Open-market sale | Common Stock | 7,725 | $21.77 | $168K | |
| Timothy Eugene Sullivan - Officer | Open-market sale | Common Stock | 10,287 | $21.77 | $224K | |
| David O. Watson - Officer | Open-market sale | Common Stock | 7,832 | $21.77 | $170K | |
| Caroline Baumal - Officer | Open-market sale | Common Stock | 1,882 | $19.79 | $37K | |
| James George Chopas - Officer | Open-market sale | Common Stock | 726 | $19.79 | $14K | |
| Mark Jeffrey Delong - Officer | Open-market sale | Common Stock | 1,334 | $19.79 | $26K | |
| Pascal Deschatelets - Officer | Open-market sale | Common Stock | 909 | $19.79 | $18K | |
| Cedric Francois - Officer | Open-market sale | Common Stock | 8,182 | $19.79 | $162K | |
| Nur Nicholson - Officer | Open-market sale | Common Stock | 2,203 | $19.79 | $44K | |
| Timothy Eugene Sullivan - Officer | Open-market sale | Common Stock | 2,892 | $19.79 | $57K | |
| David O. Watson - Officer | Open-market sale | Common Stock | 2,475 | $19.79 | $49K | |
| James George Chopas - Officer | Open-market sale | Common Stock | 873 | $22.19 | $19K | |
| Mark Jeffrey Delong - Officer | Open-market sale | Common Stock | 1,780 | $22.19 | $39K | |
| Pascal Deschatelets - Officer | Open-market sale | Common Stock | 2,277 | $22.19 | $51K | |
| Cedric Francois - Officer | Open-market sale | Common Stock | 10,186 | $22.19 | $226K | |
| Nur Nicholson - Officer | Open-market sale | Common Stock | 2,618 | $22.19 | $58K | |
| Timothy Eugene Sullivan - Officer | Open-market sale | Common Stock | 3,856 | $22.19 | $86K | |
| David O. Watson - Officer | Open-market sale | Common Stock | 5,780 | $22.19 | $128K | |
| David O. Watson - Officer | Option exercise | Common Stock | 888 | $14.95 | $13K | |
| David O. Watson - Officer | Option exercise | Stock Option (Right to Buy) | 888 | $0.00 | - | |
| Caroline Baumal - Officer | Open-market sale | Common Stock | 3,020 | $25.53 | $77K | |
 Alec Machiels - Director | Grant or award | Common Stock | 7,961 | $0.00 | - | |
| Alec Machiels - Director | Grant or award | Stock Option (Right to Buy) | 14,684 | $0.00 | - | |
APLS insider trading FAQ
What is the latest insider trade for APLS?
Apellis Pharmaceuticals, Inc. (APLS) has filed no insider reports in the last 90 days. The most recent on record is dated 2026-05-14. The full record for APLS runs to 89 Form 4 filings, the earliest from 2024-11-01. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying APLS stock?
No insider purchases of APLS were filed in the last 90 days.
How many insiders are selling APLS stock?
No insider sales of APLS were filed in the last 90 days. 47 sales are on record for this company.
Where can I see APLS SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects APLS Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - A. Sinclair Dunlop view on EDGAR
- - James George Chopas view on EDGAR
- - Mikael Dolsten view on EDGAR
- - Leslie Meltzer view on EDGAR
- - Paul R. Fonteyne view on EDGAR
- - Timothy Eugene Sullivan view on EDGAR
- - Alec Machiels view on EDGAR
- - Pascal Deschatelets view on EDGAR
- - Gerald Chan view on EDGAR
Related companies with recent insider activity
Learn more
- What the Form 4 transaction codes mean
- Grants, option exercises, gifts and tax withholding are not trades on the market. The codes say which is which.
- Insider activity in Health Care
- Where APLS's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow APLS with a 7-day demo
- APLS on your watchlist
- Every APLS Form 4 filing on record
- Up to 3 months of APLS price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
